CDIO
Cardio Diagnostics Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.36M
P/E Ratio
—
EPS
$-3.28
Beta
2.66
52W High
$17.40
52W Low
$0.97
50-Day MA
$2.70
200-Day MA
$3.40
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings Inc (CDIO) is a cutting-edge biotechnology company focused on revolutionizing cardiovascular health through its innovative diagnostic solutions. Leveraging advanced technologies, CDIO equips healthcare providers with critical tools for the accurate evaluation and management of cardiovascular diseases, ultimately enhancing patient outcomes. With a strong commitment to personalized medicine, the company is well-positioned for substantial growth, making it an appealing opportunity for institutional investors seeking exposure in a rapidly evolving healthcare sector.
Fundamentals
| Revenue (TTM) | 14,820 |
| Gross Profit (TTM) | 14,820 |
| EBITDA | $-6.09M |
| Operating Margin | -41160.00% |
| Return on Equity | -78.60% |
| Return on Assets | -44.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.82 |
| Price-to-Book | 0.87 |
| Price-to-Sales (TTM) | 361.32 |
| EV/Revenue | 111.43 |
| EV/EBITDA | -22.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.20% |
| Shares Outstanding | $2.96M |
| Float | $2.83M |
| % Insiders | 8.31% |
| % Institutions | 4.38% |
Data last updated: 4/10/2026